UPMC Hamot 2020 Neuroscience Conference: When Is a Headache Just a Headache and When to be Concerned?
This presentation was part of the UPMC Hamot 2020 Neuroscience Conference and was designed to meet requirements for Stroke credit.
Target Audience
Primary care physicians, internists, neurologists, neurosurgeons, nurses, nurse practitioners, physician assistants; physical, occupational, and speech therapists; and other advanced practice providers will benefit from this activity.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Discuss differential diagnosis of headache
- Review traditional treatment options used for headache
- Discuss new calcitonin gene-related peptide (CGRP) treatment option
Suggested Additional Reading
- Tepper et al. Lancet Neurol 2017; 16:425-434
- Skljarevski et al. AHS meeting June 2017
- Ashina et al. PO-01-180. IHC, Sept 2017
- Dodick DW. Adv Stud Med. 2003;3(6C):S550-S555.
Presenter: Karen Bellini, DO, Neurologist, UPMC Hamot
Planning Committee Members:
- Haylee Esposito, UPMC Hamot
- Tammy Kordes, PhD, Neuropsychologist, Northshore Neurosciences
- Debbie Morton, BSN, RN, NPD-BC
- Samantha Panighetti, MOT, OTR/L, NTMTC, UPMC Hamot
- Rebecca Parkhurst, PA-C, UPMC Hamot
- Margaret Pett, UPMC Hamot
- Trevor Phinney, DO, Neurologist, UPMC Northshore Neurology
- Ann Sokoloff, BSN, CNRN, Clinical Director, Ortho/Neuro Services, UPMC Hamot
- Stacy Wing, PT, UPMC Hamot
No relationships with industry relevant to the content of this educational activity have been disclosed.
Authors disclosure of relevant financial relationships with any entity producing, marketing, re-selling, or distributing health care goods or services, used on, or consumed by, patients is listed above. No other planners, members of the planning committee, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclose.
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The University of Pittsburgh School of Medicine designates this enduring material for a maximum of .75 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
The University of Pittsburgh has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for .75 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
The maximum number of hours awarded for this Continuing Nursing Education activity is .75 contact hours.
Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.
All presenters disclosure of relevant financial relationships with any entity producing, marketing, re-selling, or distributing health care goods or services, used on, or consumed by, patients is listed above. No other planners, members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclose.
Available Credit
- 0.75 AAPA Category I CME
- 0.75 AMA PRA Category 1 Credit™The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
- 0.75 ANCCUPMC Provider Unit is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation
- 0.75 Attendance